利格列汀杂质，利拉列汀杂质对照品

利格列汀杂质，利拉列汀杂质对照品 产品介绍：
中文名称：利格列汀杂质，利拉列汀杂质对照品
英文名称：Linagliptin Impurity
规格：10mg/25mg/50mg/100mg等多种规格可选。
用途：实验研发，药品申报检测，不得用于临床医学诊断。
随货提供：所有杂质对照品均随货提供HPLC，NMR，MS图谱及CoA证书。
保存及取用：为了防止产品含量降低，应防潮，避光和抗氧化包装，保存应以提高物质稳定性为原则。如果一次使用很少量，可以将其适当分装后使用，这样可以有效的防止试剂污染。请不要在脏乱和强光环境中取用，以免造成污染和失效。
 
利格列汀杂质，利拉列汀杂质对照品 杂质列表：
Linagliptin
(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 1 
 
7-(but-2-yn-1-yl)-8-((2-hydroxyethyl)amino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 2
2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide
Linagliptin Impurity 3
N-Phthalimide-linagliptin
(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 4
Linagliptin Impurity S
(R,Z)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 5
N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide
Linagliptin Impurity 6
(R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid
Linagliptin Impurity 7
Linagliptin Diene Impurity
8-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1)
Linagliptin Impurity 8
Linagliptin Acetamide
(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide
Linagliptin Impurity 9
8-bromo-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 10
(R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 11
(R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 12
8-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 13
(R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 14
(R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 15
(R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 16
(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide
Linagliptin Impurity 17
(S)-Linagliptin
(S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 18
7-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 19
N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
Linagliptin Impurity 20
(R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 21
(R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
Linagliptin Impurity 22
(R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 23
(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 24
(S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 25
(R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 26
(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide

若杂质列表中未有您需要的杂质，欢迎来电或在线详询，产品库时常会有更新，另外，我司有专业研发团队，可提供部分杂质定制服务，以可能的满足您对杂质对照品的选购需求。
 
利格列汀杂质，利拉列汀杂质对照品 订购方式：
联系人：何先生
手机：15012456311
QQ：781007885
邮箱：phastandards@gmail.com
欢迎您通过电话，电邮或在线客服向我司询价及订购产品。
 
利格列汀杂质，利拉列汀杂质对照品 深圳远扬专注医药标准品，杂质对照品，更多产品，欢迎选购（篇幅有限，只列举了一小部分，更多更全，请来电详询）：
NIBSC标准品部分产品列表：
 03/104-020 HTLV-5 (antibody) Monitor Sample
03/104-039 HTLV-24 (antibody) Monitor Sample
12/B623-086 QCRFLUAH1N1QC1-Influenza AH1N1 QC84
01/479 Meningococcal serogroup W polysaccharide
12/B623-011 QCRFLUAH1N1QC1-Influenza AH1N1 QC9
07/301 BCG Vaccine of Russian BCG-I sub-strain(28st WHO Reference Reagent)
12/B623-031 QCRFLUAH1N1QC1-Influenza AH1N1 QC29
10/131 Reteplase Reference Material
12/B623-013 QCRFLUAH1N1QC1-Influenza AH1N1 QC11
10/140 Reteplase Reference Material
10/105 Reteplase Reference Material
01/434 Meningococcal serogroup W polysaccharide
12/B623-107 QCRFLUAH1N1QC1-Influenza AH1N1 QC105
13/166 Influenza Antigen B/Massachusetts/02/2044 (Egg derived)
07/351 BCG Vaccine of Russian BCG-I sub-strain(78st WHO Reference Reagent)
13/234 C-Peptide, Human. 89st International Standard.
10/161 Reteplase Reference Material
13/238 Influenza Antigen B/Massachusetts/02/2116 (Egg derived)
13/208 C-Peptide, Human. 63st International Standard.
07/321 BCG Vaccine of Russian BCG-I sub-strain(48st WHO Reference Reagent)
13/200 C-Peptide, Human. 55st International Standard.

杂质对照品部分产品列表：
 阿维菌素杂质，法米替尼杂质，蝶酸杂质，艾代拉里斯杂质，盐酸瑞伐拉赞杂质，氯索洛芬杂质，曲伏前列素杂质，泰妙菌素杂质，左旋多巴杂质，氨基磺酸杂质，米替福新杂质，托拉塞米杂质，
他克莫司杂质，阿法替尼杂质，盐酸西那卡塞杂质，阿格列汀杂质，Lesinurad杂质，艾氟康唑杂质，地西他滨杂质，溴隐亭杂质，拉呋替丁杂质，艾普拉唑杂质，氯苯达诺杂质，氟氧头孢杂质，赖诺普利杂质，地氯雷他定杂质，屈昔多巴杂质，哌唑嗪杂质，盐酸地尔硫卓杂质

利格列汀杂质，利拉列汀杂质对照品 美国剑桥CIL标准品部分产品列表：
 CDLM-4611-PK   ALPHA-KETOBUTYRIC ACID, SODIUM SALT (13C4, 98%; 3,3-D2, 98%)
CLM-692-0.25   URACIL (4,5-13C2, 99%)
EO-5319-A-CS2   CDC BFR CALIBRATION STANDARD CS2 (UNLABELED/13C12, 99%) IN NONANE
CDNLM-6801-PK   L-ARGININE:HCL (13C6, 97-99%; D7, 97-99%; 15N4, 97-99%)
CLM-1160-0.5   ACETIC ANHYDRIDE (2,2'-13C2, 99%)
OLM-190-PK   CARBON MONOXIDE (18O, 95%)
EC-4929-1.2   2,2',3,4,4'-PENTACB (PCB-85) (13C12, 99%) 40+/-2 UG/ML IN NONANE
DLM-294-5   NITROBENZENE-D5 (D, 99%)
EC-1424-1.2   2,2',5,5'-TETRACB (PCB-52) (13C12, 99%) 40+/-2 UG/ML IN NONANE
CGM-4020-SL-C   YEAST-OD2 GROWTH MEDIA (13C, 98%)
EC-4995/50-1.2   WHO COPLANAR & MONO-ORTHO PCB + PCB-170 & PCB-180 (13C12, 99%) 20 NG/ML IN N-NONANE
DLM-1171-PK   CHLOROETHANE (D5, 98%)
DLM-1154-PK   STEARIC ACID (METHYL-D3, 98%)
N-905   NORDIAZEPAM UNLABELED 1000 UG/ML IN METHANOL
DLM-2852-1.2   1,6-DIMETHYLNAPHTHALENE (D12, 98%) 50 UG/ML IN TOLUENE-D8
D-907   DIAZEPAM UNLABELED 1000 UG/ML IN METHANOL
JR-F35-25   2,3,7,8-TETRACDF UNLABELED ~25 NG/ML IN NONANE
CLM-1017-MPT-PK   GLYCINE (1,2-13C2, 97-99%) MICROBIOLOGICAL/PYROGEN TESTED
ULM-6687-1.2   (+/-)-CHLORAMPHENICOL UNLABELED 100 UG/ML IN ACETONITRILE
CDLM-8806-KIT   IN VIVO ILVA METHYL LABELING KIT
PCBB-5273   3,4-DIBROMO-3',4'-DICB UNLABELED 100 UG/ML IN ISOOCTANE
DLM-4646-PK   ALPHA-KETOISOVALERIC ACID, SODIUM SALT (D7, 98%)
DLM-1392-0.5   TRIDECANOIC ACID (D25, 98%)
ULM-9124-0.005   VITAMIN D2 (ERGOCALCIFEROL) UNLABELED
JR-D20-25   1,4,6,9-TETRACDD UNLABELED ~25 NG/ML IN NONANE
ES-5343-CS3   POPS HRMS HCH CALIBRATION SOLUTION CS3 (UNLABELED/13C6, 99%) IN NONANE
PCB-43-C   2,2',3,5-TETRACB UNLABELED
CODE G-8   8 L CARBON STEEL CYLINDER CGA 580 PACKLESS BRASS ANGLE
DLM-9116-B   25-HYDROXYVITAMIN D3 (6,19,19-D3,97%) 50 UG/ML IN ETHANOL